anonymous
Guest
anonymous
Guest
Spinning off an asset for $250M in 2019, taking board and executive positions on the new company, only to sell it back to Novartis in 2025 for $925M has to be one of the biggest scams ever pulled off by Novartis execs. A lot of people just got very rich at NVS's expense. I smell a shareholder lawsuit coming.